C
59.42
1.42 (2.45%)
| Previous Close | 58.00 |
| Open | 59.00 |
| Volume | 7,044,780 |
| Avg. Volume (3M) | 5,724,859 |
| Market Cap | 29,999,077,376 |
| Price / Earnings (TTM) | 10.26 |
| Price / Earnings (Forward) | 8.10 |
| Price / Sales | 0.190 |
| Price / Book | 1.09 |
| 52 Weeks Range | |
| Earnings Date | 4 Feb 2025 - 10 Feb 2025 |
| Profit Margin | 2.10% |
| Operating Margin (TTM) | 2.96% |
| Diluted EPS (TTM) | 5.79 |
| Quarterly Revenue Growth (YOY) | 6.10% |
| Quarterly Earnings Growth (YOY) | 52.00% |
| Total Debt/Equity (MRQ) | 64.23% |
| Current Ratio (MRQ) | 1.10 |
| Operating Cash Flow (TTM) | 958.00 M |
| Levered Free Cash Flow (TTM) | 1.00 B |
| Return on Assets (TTM) | 3.51% |
| Return on Equity (TTM) | 11.56% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bearish | Mixed |
| Healthcare Plans (Global) | Bearish | Mixed | |
| Stock | Centene Corporation | Bearish | Bullish |
AIStockmoo Score
1.0
| Analyst Consensus | 1.5 |
| Insider Activity | 1.5 |
| Price Volatility | 1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 1.00 |
|
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Value |
| % Held by Insiders | 0.27% |
| % Held by Institutions | 99.72% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 30 Sep 2024 | 12,135,044 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 93.00 (Barclays, 56.51%) | Buy |
| Median | 84.00 (41.37%) | |
| Low | 52.00 (Jefferies, -12.49%) | Sell |
| Average | 79.64 (34.03%) | |
| Total | 8 Buy, 2 Hold, 1 Sell | |
| Avg. Price @ Call | 59.85 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 17 Dec 2024 | 75.00 (26.22%) | Buy | 57.81 |
| Barclays | 13 Dec 2024 | 93.00 (56.51%) | Buy | 59.42 |
| 29 Oct 2024 | 91.00 (53.15%) | Buy | 60.62 | |
| Oppenheimer | 13 Dec 2024 | 85.00 (43.05%) | Buy | 59.42 |
| Stephens & Co. | 13 Dec 2024 | 73.00 (22.85%) | Hold | 59.42 |
| Truist Securities | 13 Dec 2024 | 84.00 (41.37%) | Buy | 59.42 |
| UBS | 13 Dec 2024 | 80.00 (34.63%) | Buy | 59.42 |
| Cantor Fitzgerald | 11 Dec 2024 | 90.00 (51.46%) | Buy | 56.90 |
| 01 Oct 2024 | 90.00 (51.46%) | Buy | 73.94 | |
| Jefferies | 10 Dec 2024 | 52.00 (-12.49%) | Sell | 56.71 |
| Wells Fargo | 04 Nov 2024 | 90.00 (51.46%) | Buy | 63.82 |
| Bernstein | 30 Oct 2024 | 88.00 (48.10%) | Buy | 61.78 |
| Baird | 25 Oct 2024 | 66.00 (11.07%) | Hold | 64.22 |
| Show more | ||||
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ASHER ANDREW LYNN | - | 59.42 | -1,924 | -114,324 |
| BLUME JESSICA L. | 59.17 | - | 250 | 14,793 |
| COUGHLIN CHRISTOPHER J | 59.17 | - | 10,000 | 591,700 |
| DALLAS H JAMES | 59.17 | - | 1,693 | 100,175 |
| KOSTER CHRISTOPHER | - | 59.42 | -2,518 | -149,620 |
| LONDON SARAH | - | 59.42 | -2,158 | -128,228 |
| SAMUELS THEODORE R. II | 59.42 | - | 5,000 | 297,100 |
| Aggregate Net Quantity | 10,343 | |||
| Aggregate Net Value ($) | 611,595 | |||
| Aggregate Avg. Buy ($) | 59.23 | |||
| Aggregate Avg. Sell ($) | 59.42 | |||
| Insider Range ($) | ||||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| COUGHLIN CHRISTOPHER J | Director | 16 Dec 2024 | Buy (+) | 10,000 | 59.17 | 591,700 |
| BLUME JESSICA L. | Director | 16 Dec 2024 | Buy (+) | 250 | 59.17 | 14,793 |
| DALLAS H JAMES | Director | 16 Dec 2024 | Buy (+) | 1,693 | 59.17 | 100,175 |
| LONDON SARAH | Officer | 15 Dec 2024 | Disposed (-) | 2,158 | 59.42 | 128,228 |
| ASHER ANDREW LYNN | Officer | 15 Dec 2024 | Disposed (-) | 1,924 | 59.42 | 114,324 |
| KOSTER CHRISTOPHER | Officer | 15 Dec 2024 | Disposed (-) | 2,518 | 59.42 | 149,620 |
| SAMUELS THEODORE R. II | Director | 13 Dec 2024 | Buy (+) | 5,000 | 59.42 | 297,100 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |